...
首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Rapid antimicrobial susceptibility testing of clinical isolates by digital time-lapse microscopy
【24h】

Rapid antimicrobial susceptibility testing of clinical isolates by digital time-lapse microscopy

机译:通过数字延时显微镜对临床分离株进行快速药敏试验

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Rapid antimicrobial susceptibility testing (AST) is essential for early and appropriate therapy. Methods with short detection time enabling same-day treatment optimisation are highly favourable. In this study, we evaluated the potential of a digital time-lapse microscope system, the oCelloScope system, to perform rapid AST. The oCelloScope system demonstrated a very high accuracy (96 % overall agreement) when determining the resistance profiles of four reference strains, nine clinical isolates, including multi-drug-resistant isolates, and three positive blood cultures. AST of clinical isolates (168 antimicrobial agent-organism combinations) demonstrated 3.6 % minor, no major and 1.2 % very major errors of the oCelloScope system compared to conventional susceptibility testing, as well as a rapid and correct phenotypic detection of strains with methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum beta-lactamase (ESBL) profiles. The net average time-to-result was 108 min, with 95 % of the results being available within 180 min. In conclusion, this study strongly indicates that the oCelloScope system holds considerable potential as an accurate and sensitive AST method with short time-to-result, enabling same-day targeted antimicrobial therapy, facilitating antibiotic stewardship and better patient management. A full-scale validation of the oCelloScope system including more isolates is necessary to assess the impact of using it for AST.
机译:快速的抗菌药物敏感性测试(AST)对于早期和适当的治疗至关重要。检测时间短,可实现当日治疗优化的方法非常受欢迎。在这项研究中,我们评估了数字延时显微镜系统oCelloScope系统执行快速AST的潜力。 oCelloScope系统在确定四种参考菌株,九种临床分离株(包括耐多药分离株)和三种阳性血液培养物的耐药谱时,显示出很高的准确性(总体一致性为96%)。与传统药敏测试相比,临床分离株的AST(168种抗菌剂-生物体组合)显示oCelloScope系统的轻微错误,无重大错误和非常重大的1.2%的错误,以及对甲氧西林耐药菌株的快速正确的表型检测金黄色葡萄球菌(MRSA)和广谱β-内酰胺酶(ESBL)谱。净平均产生时间为108分钟,其中95%的结果可在180分钟内获得。总而言之,这项研究强烈表明,oCelloScope系统作为一种准确,灵敏的AST方法,具有较短的结果生成时间,可实现当天的靶向抗微生物治疗,促进抗生素管理和更好的患者管理,具有巨大的潜力。为了评估将其用于AST的影响,有必要对oCelloScope系统进行全面验证,其中包括更多的分离株。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号